UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036522
Receipt number R000041584
Scientific Title Investigator-initiated clinical trial for progressive supranuclear palsy using an anti-cholinergic drug
Date of disclosure of the study information 2019/04/16
Last modified on 2020/04/15 12:07:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigator-initiated clinical trial for progressive supranuclear palsy using an anti-cholinergic drug

Acronym

Clinical trial for PSP using anticholinergic drug

Scientific Title

Investigator-initiated clinical trial for progressive supranuclear palsy using an anti-cholinergic drug

Scientific Title:Acronym

Clinical trial for PSP using anticholinergic drug

Region

Japan


Condition

Condition

Progressive supranuclear palsy

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Efficacy of trihexyphenidyl hydrochloride for freezing symptoms (akinesia) due to progressive supranuclear palsy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Difference of summation of scores 13-15, and 29-30 items of UPDRS and 2.12-2.13 items of MDS-UPDRS between pretreatment and 3 months after the treatment

Key secondary outcomes

Score of PSPRS, MMSE, FAB, MoCA, volume of voice, voice duration, timed up & go test, score of FOGQ, modified Schwab & England ADL scale, frequency of urination, and side effect


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Trihexyphenidyl hydrochloride max.3mg for 3 months

Interventions/Control_2

Placebo max. 3mg for 3 months

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)>=40 years old patient with progressive supranuclear palsy (PSP) when obtained informed consent
2) sporadic PSP
3) slowly progressive course
4)patient with freezing gait: the patients meet MDS-PSP criteria such as [probable PSP-RS(O1 or O2)+(P1 or P2), probable PSP-PGF (O1 or O2)+A1, possile PSP-RS (O2 +P3) or possible PSP-PGF A1]
5) severity of PSP 1-5 (except for 6)
6) >=15 points of MMSE score
7) existence of reliable care giver for the patient
8) researcher can obtain the written consent from the patient.
Included a patient who meets the aobove mentioned all items.

Key exclusion criteria

1) attending other clinical trials
2) alcohol dependence or drug abuser
3) psychiatric disorder
4) allergy for anti-cholinergic drugs
5) severe liver or renal dysfunction
6) effective for levodopa, and/or using following drugs: anti-psychiatric agents, anti-epileptic drugs, acethycholine esterase inhibitor, memantine, immunosuppressant, corticosteroids, anti-coagulant, lithium, or anti-cholinergic drug
7) not suitable for clinical trial judged by principal investigator or researchers.

Target sample size

32


Research contact person

Name of lead principal investigator

1st name Takayoshi
Middle name
Last name Shimohata

Organization

Gifu University Graduate School of Medicine

Division name

Department of Neurology

Zip code

5011194

Address

1-1 Yanagido, Gifu

TEL

058-230-6000

Email

shimohata@gmail.com


Public contact

Name of contact person

1st name Yuichi
Middle name
Last name Hayashi

Organization

Gifu University Graduate School of Medicine

Division name

Department of Neurology

Zip code

501194

Address

1-1 Yanagido, Gifu

TEL

0582306254

Homepage URL

http://www.med.gifu-u.ac.jp/neurology/research/psp.html

Email

hayashiy@gifu-u.ac.jp


Sponsor or person

Institute

1) Department of Neurology, Gifu University Graduate School of Medicine,
2) National Hospital Organization, Higashi Nagoya Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gifu University Graduate School of Medicine

Address

1-1 Yanagido, Gifu

Tel

058-230-6000

Email

rinri@gifu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岐阜大学医学部附属病院(岐阜県)/Gifu University Hospital
国立病院機構 東名古屋病院(愛知県)/National Hospital Organization Higashi Nagoya Hospital


Other administrative information

Date of disclosure of the study information

2019 Year 04 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 04 Month 03 Day

Date of IRB

2019 Year 04 Month 03 Day

Anticipated trial start date

2019 Year 04 Month 15 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 04 Month 15 Day

Last modified on

2020 Year 04 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041584


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name